Research On Core Competitiveness Evaluation Model Of Drug Circulation Enterprises

Drug circulation enterprises play a connecting role in the whole drug distribution value chain.Due to the complexity and particularity of the pharmaceutical circulation environment,the drug circulation market is relatively scattered,meanwhile disorderly competition is serious.In recent years,with the implementation of policies such as'two-vote system' and '4+7' drug volume procurement,there are many uncertainties in the development of the industry.Drug circulation enterprises are facing major opportunities and challenges in transformation and upgrading,and market competition is becoming increasingly fierce.How to evaluate the core competitiveness effectively and find the direction of development,that will be an urgent issue for drug circulation enterprises.This research was based on the analysis of the development and reform trends of China's drug circulation industry and the competitive landscape of domestic and foreign drug circulation enterprises,Porter's five-force model theory was used to explore the competitive environment in China's drug circulation enterprises.The results show that the competition among China's drug circulation enterprises is fierce and the bargaining power is weak when trading with manufacturing enterprises and medical institutions.At the same time,it is necessary to be alert to the entry and substitution threats from Internet pharmaceutical enterprises and third-party pharmaceutical logistics.The study believes that expanding enterprise scale,improving network layout,developing emerging service business and giving full play to regional advantages can help drug circulation enterprises to improve their bargaining power,resist external shocks and enhance their core competitiveness.Through the expert consultation method,the necessity and the importance degree of the core competitiveness evaluation indicators for drug circulation enterprises were investigated.And then statistically analyzed the opinions and authority of the experts.As a result,the core competitiveness evaluation model of drug circulation enterprises was established and the meaning of the indicators was explained.At the same time,the model results include four first-level indicators,eight second-level indicators and 26 third-level indicators,the four items in first-level indicators was scale,network,service,and "base camp" advantages.It provides an evaluation tool in line with the current industry development for the core competitiveness evaluation of drug circulation enterprises.According to the expert consultation data,the analytic hierarchy process was used to construct the judgment matrix to calculate the index weight at all levels and to check the consistency of the results,in which the first-level index weight is 0.0890,the network is 0.4328,the service is 0.2391,and the advantage of "base camp" is 0.2391.Then,based on the analysis and discussion of the weight results,it was found that four indicators in the three-level indicators had the highest proportion of weight in the hierarchical ranking.It was the hospital net selling network,in-hospital and out-of-hospital auxiliary diagnosis and treatment services,the terminal distribution network and the regional share of the pure selling market,which represent the key development direction of the current drug circulation enterprises'core competitiveness.To provide a quantitative research basis and operational example for the core competitiveness comprehensive evaluation of China's drug circulation enterprises,Chongqing Pharmaceutical(Group)Co.,Ltd.was selected as the research object.Firstly,conduct the background research to the empirical enterprise;then,statistically analyze the 192 valid data in the questionnaire survey among the enterprise managers;further more,use the fuzzy comprehensive evaluation method to conduct the three-level fuzzy comprehensive evaluation.The evaluation results show that Chongqing Pharmaceutical Group had a strong level of core competitiveness,and the score was 70.2 according to V={90,70,50,50,10},indicating that the enterprise still had a lot of space for improvement.According to the evaluation results of the core competitiveness model,it can exert its competitive advantages in the strong fields,pay attention to the weak areas and make up for the shortcomings,and continue to enhance the core competitiveness for sustainable development.